You are here: Industry Insights > FDA

News List

Second COVID-19 vaccine ‘Spikevax’ is approved by the FDA EuropeanPharmaceuticalReview
February 10, 2022
The FDA has approved a second vaccine, marketed as Spikevax, shown to be 93 percent effective in preventing COVID-19.
FDA Raises Concerns About China-Developed Drugs FirstWordPharma
February 10, 2022
A negative FDA staff report for Eli Lilly and partner Innovent Biologics' anti-PD-1 cancer drug sintilimab could slow the plans of large Western drugmakers such as Novartis looking to sell Chinese-tested medicines...
Cabenuva HIV treatment approved for eight week dosing EuropeanPharmaceuticalReview
February 09, 2022
ViiV Healthcare has announced the US Food and Drug Administration’s (FDA) approval of Cabenuva (cabotegravir, rilpivirine) in the treatment of HIV.
CDER BIMO GCP Compliance and Enforcement FDA
February 09, 2022
This webinar will:provide a general overview of the Bioresearch Monitoring (BIMO) program...
Need for Speed: Kidney cancer patients waiting three times longer pharmatimes
February 08, 2022
Need for Speed: Kidney cancer patients waiting three times longer.
FDA takes key action by approving second COVID-19 vaccine WorldPharmaNews
February 07, 2022
The U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine.
CDC Backs Full Approval of Moderna COVID Vaccine drugs.com
February 04, 2022
The U.S. Centers for Disease Control and Prevention on Friday gave its full approval to Moderna's COVID-19 vaccine for use in people 18 and older.
Cytokinetics Announces FDA Acceptance of New Drug Application for Omecamtiv Mecarbil for the Treatment of Heart Failure With Reduced Ejection Fraction drugs.com
February 04, 2022
Federal health officials announced Friday that they are expanding nationwide efforts to track COVID-19 by monitoring virus levels found in raw sewage.
B. Braun Receives FDA Approval of Daytona Beach Pharmaceutical Manufacturing Site contractpharma
February 03, 2022
Increased availability of IV solutions to address shortages stemming from ongoing COVID-19 crisis.
Easier to produce COVID vaccine shows promise in trials; nasal spray vaccine booster works in mice FirstWordPharma
January 29, 2022
Dizal Pharmaceutical Co., Ltd. (SHEX:688192) ("Dizal"), today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation to DZD9008 (Sunvozertinib) for the treatment of patients...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 365 366 Next page